Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating a Patient Navigation Program to Improve Therapy Management for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib

NCT06983691 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT06983691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06983691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating a Patient Navigation Program to Improve Therapy Management for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Recruiting
Start date
August 11, 2026
Completion date
March 31, 2027
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2+ metastatic breast cancer (mbc)